Author

Blessing Ojika

Institution: National Hospital Abuja

Observed institution: National Hospital Abuja

OpenAlex ID: A5117859008

Safety and efficacy of pociredir in adults with severe sickle cell disease and hydroxyurea intolerance or unresponsiveness: results from the phase 1b PIONEER study

2026 · Sheinei S Alan, Johnny Mahlangu, et al. · Journal of sickle cell disease.

A Phase 1b, Open-label, Multiple-Dose Study Evaluating Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Pociredir in Patients With Sickle Cell Disease (SCD): Trial Design

2025 · Sheinei Alan, Johnny Mahlangu, et al. · Journal of sickle cell disease.

Works count: 2

Citation count:

H-index:

I10-index: